Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years

We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shida, Yohei, Hakariya, Tomoaki, Miyata, Yasuyoshi, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378862/
https://www.ncbi.nlm.nih.gov/pubmed/28396761
http://dx.doi.org/10.1002/ccr3.854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378862/
https://www.ncbi.nlm.nih.gov/pubmed/28396761
http://dx.doi.org/10.1002/ccr3.854

Ejemplares similares